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ABSTRACT 
MBD4 is the only methyl-CpG binding protein that possesses a C-terminal glycosylase domain. 
It has been associated with a number of nuclear pathways including DNA repair, DNA damage 
response, the initiation of apoptosis, transcriptional repression and DNA demethylation. 
However, the precise contribution of MBD4 to these processes in development and relevant 
diseases remains elusive. We identified UHRF1 and USP7 as two new interaction partners for 
MBD4. Both UHRF1, a E3 ubiquitin ligase, and USP7, a de-ubiquinating enzyme, regulate the 
stability of the DNA maintenance methyltransferase, Dnmt1. The ability of MBD4 to directly 
interact with and recruit USP7 to chromocenters implicates it as an additional factor that can 
potentially regulate Dnmt1 activity during cell proliferation. 
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MBD4 is the only methyl-CpG binding protein that possesses a C-terminal glycosylase domain. It has 
been associated with a number of nuclear pathways including DNA repair, the DNA damage response, 
initiation of apoptosis, transcriptional repression and DNA demethylation [Bellacosa et al., 1999; 
Cortellino et al., 2003; Hendrich et al., 1999; Meng et al., 2011; Rai et al., 2008; Ruzov et al., 2009; 
Screaton et al., 2003; Thillainadesan et al., 2012]. A naturally occurring frameshift mutation in MBD4 
results in a truncated protein, lacking its intervening region and glycosylase domain, occurs in human 
colon and other carcinomas that exhibit microsatellite instability (MSI), generally associated with 
defects in mismatch repair (MMR) [Bader et al., 1999; Bader et al., 2007; Riccio et al., 1999]. 
However, mutant mice targeted to create an Mbd4 null mutation did not exhibit increased 
tumorigenesis, reduced survival rates, or increased MSI; although a 2-3 fold increase in G:T mutation 
at CpG sites was observed [Millar et al., 2002; Wong et al., 2002]. Loss of MBD4 function also does 
not affect MMR-dependent tumorigenesis [Sansom et al., 2004; Sansom et al., 2003], however it plays 
a role in mediating the apoptotic response resulting from exposure to DNA damaging agents or 
inactivation of the maintenance methyltransferase, Dnmt1 [Loughery et al., 2011; Ruzov et al., 2009; 
Sansom et al., 2003]. Depletion of DNMT1 in cancer cell lines can result in decreases in MMR protein 
levels, including MBD4, possibly mediated by their physical interaction [Laget et al., 2014; Loughery 
et al., 2011; Ruzov et al., 2009]. MBD4 strongly associates with heterochromatin [Hendrich and Bird, 
1998; Ruzov et al., 2009], and has also been shown to physically interact with and recruit MMR 
protein MLH1 (MutL homolog 1) to heterochromatin sites during MMR-dependent apoptosis 
[Bellacosa et al., 1999; Cortellino et al., 2003; Ruzov et al., 2009]. These findings suggest that MBD4 
may have additional roles [Cortellino et al., 2003], possibly through unknown protein associations of 
MBD4 that can contribute to genome stability. Indeed, MBD4 interacting proteins such as Fas-
associated death domain protein (FADD), MLH1 and DNA methyltransferase 1 (DNMT1) potentially 
link genome surveillance and DNA repair with apoptosis during cell proliferation and DNA replication 
[Ruzov et al., 2009; Screaton et al., 2003].  
UHRF1 (Ubiquitin-like, with PHD and RING finger domains 1, also known as Np95 and ICBP90) 
interacts with and recruits DNMT1 to hemi-methylated DNA to facilitate methylation of daughter 
strands [Bostick et al., 2007; Sharif et al., 2007]. It also has a binding specificity for 5-
hydroxymethylcytosine (5hmC)-containing DNA that is similar to its affinity for 5-methylcytosine 
DNA [Rajakumara et al., 2011]. UHRF1 is strongly linked to heterochromatin replication and 
formation [Papait et al., 2008; Papait et al., 2007], which may depend on its specific localization 
during cell proliferation to the chromocenters (via modified histones) that undergo large-scale 
reorganization and progressive clustering at heterochromatin regions [Nishiyama et al., 2013; Papait et 
al., 2008]. UHRF1 is preferentially expressed in the cells undergoing proliferation [Papait et al., 2008], 
during which UHRF1 forms a complex with Dnmt1 and USP7 (ubiquitin specific peptidase 7, herpes 
virus-associated, also known as HAUSP) [Felle et al., 2011; Ma et al., 2012; Qin et al., 2011]. USP7 
regulates the stability of UHRF1 via its deubiquitylase activity [Felle et al., 2011; Ma et al., 2012; Qin 
et al., 2011], and modulates the enzymatic activity of Dnmt1 on the UHRF1 platform [Bostick et al., 
2007; Felle et al., 2011; Qin et al., 2011; Sharif et al., 2007]. However, the nuclear distribution pattern 
of USP7 per se, is generally diffuse [Holowaty et al., 2003; van der Horst et al., 2006] and is similar to 
that of MLH1 [Ruzov et al., 2009], which contrasts with the strong heterochromatin and chromocenter-
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associated expression of UHRF1 during cell proliferation [Dunican et al., 2013]. USP7 can be 
recruited and relocated to nuclear foci by its protein partners [Daubeuf et al., 2009; Everett et al., 1997; 
Zaman et al., 2013], and previous studies have suggested a direct interaction between USP7 and 
UHRF1 [Felle et al., 2011; Ma et al., 2012]. However, this interaction may be transient and 
stabilization of the trimeric USP7/UHRF1/DNMT1 complex has been suggested to depend on their 
mutual engagement on chromatin [Felle et al., 2011].  
In this study we performed biochemical isolation and identification of MBD4 associating proteins, 
and we found that MBD4 specifically interacts with UHRF1 and USP7. We characterized a novel 
interaction domain in the intervening region of MBD4 and demonstrate a direct role for MBD4 in 
recruiting USP7 to chromocenters. 
 
MATERIALS AND METHODS 
PLASMID CONSTRUCTION AND CELL CULTURE 
The following plasmids were kindly provided by the laboratories below: SF-TAP (Dr Marius Ueffing) 
[Gloeckner et al., 2007], HA-UHRF1, FLAG-UHRF1 (Dr John Peter McPherson) [Mistry et al., 2008], 
MCherry-USP7 (Drs Heinrich Leonhardt and Fabio Spada) [Qin et al., 2011]. GFP-MLH1 [Ruzov et 
al., 2009], FLAG-p75 (Drs Madapura M. Pradeepa and Wendy A. Bickmore) [Pradeepa et al., 2012], 
GFP-mMBD4 (Dr Adrian Bird) [Hendrich and Bird, 1998], p21b-TF-UB vector (Dr Il-Seon Park) 
[Thapa et al., 2008]. To make FLAG-hMBD4 (SF-TAP-hMBD4), human full length MBD4 was 
cloned to SF-TAP vector using EcoRI and NotI. To make 6HIS-TF-UB-hMBD4 mutants, the 18-
amino acid (aa) 6-HIS tag was induced into the upstream of TF-UB site of the original p21b-TF-UB 
vector, using the QuikChange site-directed mutagenesis kit (Stratagene). Human MBD4 mutants were 
then cloned to the p21b-6his-TF-UB vector using BamhI and XhoI. CMT93 and HEK293T were 
cultured in Dulbecco's Modified Eagle Medium (DMEM; Invitrogen) supplemented with 10% FCS, 
1000U/ml Pen, and 650μg/ml Strep. 
NUCLEAR EXTRACT PREPARATION AND IMMUNOPRECIPITATION 
Nuclear extract was prepared from HEK293T cells according to [Pradeepa et al., 2012]. HEK293T 
were transfected with SF-TAP-hMBD4 and were lysed with a hypotonic lysis buffer (0.05% NP-40, 10 
mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 5 mM EDTA, and complete protease inhibitor cocktail 
(Roche), pH 7.4, 30 x 10
6
 cells/ml). Cytosolic fraction was discarded and the separated cell nuclei 
were lysed in a nuclear extract buffer (20 mM HEPES, 300 mM NaCl, 20 mM KCl, EDTA-free 
complete protease inhibitor cocktail (Roche), pH 7.4, 30 x 10
6
 cells/ml) with or without MNase 
(Nuclease S7; Roche) as indicated in the result chapter. A final concentration of 5mM EDTA was used 
to stop the chromatin digestion if MNae is added, and the sample was centrifuged at 20,000g for 30 
minutes twice to get post nuclear supernatants. 50ul sepharose beads covalently conjugated to Flag- 
specific mAb (Sigma) or GFP beads (ChromoTek) were added to samples and incubated for 2 hours 
with rotation at 4°C. Beads were washed three times with ice-cold nuclear extract buffer containing 
0.05% NP40, and once with pure ice-cold PBS. Bound proteins were eluted by boiling in sample 
buffer, and the eluted samples were loaded on a large 10% SDS-PAGE (BioRad) and separated, 
followed by Western Blot analysis.  
MASS SPECTROMETRY (MS) ANALYSIS 
For MS analysis, gels were stained with Colloidal Blue (NuPAGE, Invitrogen). Several chunks of 
bands of diverse molecular weights were excised from the experimental and control lane of a 
corresponding molecular weights. The gel chunks were sent to St. Andrews Mass Spectrometry 
services for analysis. The gel chunk was excised and cut into 1mm cubes. These were then subjected to 
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in-gel digestion, using a ProGest Investigator in-gel digestion robot (Genomic Solutions, Ann Arbor, 
MI) using standard protocols [Shevchenko et al., 1996]. The MS/MS data file generated was analyzed 
using the Mascot 2.1 search engine (Matrix Science, London, UK) against the NCBInr database Feb 
2011 (12852469 sequences) with no species restriction.  
TRANSIENT TRANSFECTION, RECIPROCAL PULL-DOWN ASSAY AND WESTERN 
BLOT ANALYSIS 
Lipofectamine 2000 (Invitrogen) was used in accordance with manufacturer’s instructions. For 
reciprocal pull-down assays, cell nuclear lysates (without chromatin digestion) from 293T cells that 
were transiently transfected with plasmids containing FLAG-UHRF1 or GFP-Mlh1 were mixed with 
purified 6HIS-TF-UB human MBD4 mutants that were pre-incubated with Ni-NTA agarose 
(Invitrogen) overnight at 4 °C on a rotating wheel. After 1 hour incubation at 4 °C, the mixture 
containing agarose beads was loaded onto a column, followed by extensive washes (4 X) with RIPA 
buffer followed by pure ice-cold PBS. The Ni-NTA agarose was then immediately boiled in loading 
buffer for western blotting analysis. Western blots were probed with the following primary antibodies: 
anti-FLAG antibody (Sigma; mouse F1804, rabbit F7425), anti-GFP (Roche, mouse 11814460001), 
anti-MCherry (Chromotek, RFP antibody [5F8]), anti-6HIS antibody (gift from Anne Seawright, MRC 
Human Genetics Unit).  
EXPRESSION AND PURIFICATION OF PROTEINS FROM E. COLI 
The respective 6-HIS-TF-UB hMBD4 mutants were transformed into BL21-CodonPlus®(DE3)-RIPL 
cells (Agilent Technologies) in accordance with manufacturer’s instructions. Cells were harvested and 
resuspended in either 20 ml BugBuster® Protein Extraction Reagent (Novagen) with 1μl/ml 
Benzonase Nuclease (Novagen), or buffer A [50 mM Na2HPO4/NaH2PO4, pH 7.4, 300 mM NaCl, 10 
mM imidazole, 10 mM 2-mercaptoethanol (2-ME), 30% glycerol] containing 1 mM 4-(2-aminoethyl) 
benzenesulfonyl fluoride (AEBSF). The cells were then lysed by sonication, or with BugBuster reagent. 
The soluble fraction was recovered after centrifugation for 30 min at 15,000g at 4°C. The 6xHis-
tagged protein was purified by a standard protocol on Nickel agarose (Invitrogen). Proteins were 
generally eluted with either in a Tris- or a phosphate-based buffer containing 200 mM imidazole, 150–
300 mM NaCl, 1 mM  beta-mercaptoethanol, and glycerol if required. After SDS–PAGE analysis to 
judge yield and purity, the eluted protein was dialyzed against buffer (50 mM Tris- or phosphate-based 
buffer, pH 8.0, containing 150–300 mM NaCl and 1 mM beta-mercaptoethanol, and glycerol as 
necessary) to remove imidazole.  
IMMUNOFLUORESCENCE 
The mouse colon cancer cell line, CMT93, was grown on slides and were fixed in 4% 
paraformaldehyde (pFa) as previously described [Pradeepa et al., 2012]. The primary antibodies were 
anti-FLAG antibody (Sigma; mouse F1804, rabbit F7425). Secondary antibodies (Goat α-rabbit IgG-
Alexafluor Red conjugate (Invitrogen); Goat α-mouse IgG-Alexafluor Green conjugate (Invitrogen)) 
were diluted 1:1000 in block solution. Coverslips were mounted in 'Vectashield' mounting media 
(Vector Laboratories) (250ng/ml DAPI pre-mixed).  Fluorescence images were taken using a 
Hamamatsu Orca AG CCD camera (Hamamatsu Photonics), Zeiss Axioplan II fluorescence 
microscope with Plan-neofluar objectives and Chroma #83000 triple band pass filter set (Chroma 
Technology), and 'IP Lab' software was used for image analysis. 
YEAST TWO-HYBRID  
The Y2H assays were performed as previously described [Dellaire et al., 2002]. The full length mouse 
MBD4 was cloned into a GAL4 BD-Bait construct pGBKT7 (Clontech). Yeast strains carrying each 
plasmid were mated with a strain pretransformed with a mouse embryonic day 11.5 cDNA library 
cloned into pGADT7 (Clontech). Bait and library clone interaction was identified by β-Galactosidase 
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assays and appropriate dropout selections and confirmation of restreaking. Confirmed colonies were 
picked for following colony PCR and plasmid rescue followed by sequencing confirmation.  
RESULTS 
MBD4 FORMS COMPLEXES WITH UHRF1 AND USP7  
In order to identify MBD4 interaction partners, we carried out affinity purification of FLAG epitope-
tagged MBD4 from 293T cells using nuclei extracts prepared with micrococcal nuclease (MNase) 
digestion (Figure 1A). We identified UHRF1 and USP7 as two novel interacting proteins by mass 
spectrometry of the excised regions (Figure 1A. two brackets). To verify the specific interaction 
between MBD4 and the two protein partners UHRF1 and USP7, and to clarify if their associations are 
chromatin-interaction dependent, we preformed immunoprecipitations (IPs) with FLAG epitope-
tagged human MBD4 in MNase digested nuclear extracts, as well as with GFP epitope-tagged mouse 
MBD4 in nuclear extracts without chromatin digestion (Figure 1B. UHRF1 left & USP7 right). In 
addition, a reciprocal IP was carried out with FLAG epitope-tagged human UHRF1 in MNase digested 
nuclear extracts (Figure 1B. UHRF1 lower lane). The presence of UHRF1, USP7 as well as MBD4 in 
a reciprocal IP was tested by Western Blot analysis. MBD4 IP showed co-precipitation of UHRF1 and 
USP7 in both conditions with and without chromatin digestion (Figure 1B. UHRF1 upper two lanes), 
suggesting these interactions are direct and independent from chromatin binding. Human and mouse 
MBD4 exhibited similar affinity with UHRF1 (Figure 1B. UHRF1 upper three lanes) and USP7 
(Figure 1B. USP7), and MBD4 showed a similar interaction by IP with human and mouse versions of 
UHRF1 (Figure 1B. UHRF1 upper three lanes), suggesting their interaction is specific and conserved 
between human and mouse. In addition, a reciprocal IP of UHRF1 precipitated MBD4 (Figure 1B. 
UHRF1 lower lane). A co-IP of MBD4 and Mlh1 confirmed their positive interaction (Figure 1B. 
positive control), while the negative control p75 was not precipitated with MBD4 (Figure 1B. negative 
control), consistent with the previous reports [Bellacosa et al., 1999; Pradeepa et al., 2012]. 
Collectively, our data show that MBD4 can interact with UHRF1 and USP7. 
 
MBD4 INTERACTS WITH UHRF1 COMPLEX THROUGH ITS INTERVENING REGION 
To identify the protein domains of MBD4 mediating the association with UHRF1 complex, we 
purified the recombinant MBD4 proteins containing the MBD domain (amino acid 1–156), the MBD 
and the intervening region (amino acid 1–408), the glycosylase domain and its known upstream 
interaction region (amino acid 408–580), and the intervening region and the downstream interaction 
region (156-455) (Figure 2A & B). The four truncated versions of MBD4 were designed to represent 
the MBD, the intervening region, and glycosylase domains of MBD4, and to overlap with each other to 
minimize the interacting regions that may be responsible for partner protein associations (Figure 2A). 
These mutants were 6xHis-tagged fusion proteins that have a thermostable protein called ‘Trigger 
Factor’ as well as ubiquitin at its C-terminal region (Fig. 2B upper), which allows for the isolation of 
soluble fusion proteins [Thapa et al., 2008]. The four versions of human MBD4 were cloned into the 
prokaryotic expression vector, induced and purified from E.coli; individual elutions were collected for 
the respective mutants (Fig. 2B lower). Reciprocal in vitro pull-down experiments were performed 
using the purified proteins to identify the domains interacting with FLAG epitope-tagged UHRF1 
A
cc
ep
te
d 
A
rt
ic
le
 7 
 
 
complex purified from 293T cells (Figure 2C). GFP epitope-tagged Mlh1 was selected as positive 
control, because the interaction region of MBD4 responsible for its association with Mlh1 was 
previously identified in a previous yeast two-hybrid (Y2H) study [Millar, 2002]. Mutant 3 and 
particularly mutant 4 of MBD4 efficiently co-precipitated Mlh1 (Figure 2D upper left). An IP with 
Mlh1 also indicated an interaction with MBD4 recombinants 2, 3 and 4 (Figure 2D upper right). These 
data reveal that the interaction region of MBD4 responsible for the association with Mlh1 resides in 
the intervening region and glycosylase domain of MBD4 (Figure 2D. lower cartoon). Amino acids 
410-455 corresponds to the overlapping region between mutants 3 and 4 and likely represents the 
minimum requirement for the association (Figure 2D. lower cartoon). This was consistent with the 
previous Y2H study in which amino acid 415-420 of MBD4 was mapped as MBD4 minimum 
interaction region with Mlh1 [Millar, 2002]. We then tested the interaction region of MBD4 with 
UHRF1 (Figure 2E). Mutants 2 and 4 of MBD4 efficiently co-precipitated UHRF1 in vitro, while 
mutants 1 and 3, containing the MBD and glycosylase domain respectively, were not capable of 
interacting with UHRF1 (Figure 2E. upper left). Reciprocal IP of UHRF1 strongly co-precipitated 
mutant 2 of MBD4, by contrast, the other mutants containing MBD and glycosylase domains were 
very weak (Figure 2E. upper right). Therefore, we were able to map the interaction region of MBD4 to 
its intervening region (Figure 2E. lower). The intervening region of MBD4 does not contain an 
obvious functional domain [Meng et al., 2011], in addition, our data show that MBD4 recombinant 4 
successfully co-precipitated UHRF1 (similar to the binding of MBD4 recombinant 2) (Figure 2E. 
upper left), which contrasts to the very weak binding affinity in the reciprocal assay (Figure 2E. upper 
right). This supports the view that the intervening region of MBD4 constitutes a major protein 
interaction region. The naturally occurring MBD4 truncation at amino acid 313 in MMR-deficient 
human carcinomas presumably has the potential to affect the protein interaction profile of MBD4 in 
addition to losing the catalytically active C-terminal glycosylase domain (Figure 2A, black arrow). 
Taken together, our in vitro studies show that MBD4 can directly interact with UHRF1, and the 
intervening region of MBD4 can mediate the association. 
 
MBD4 TIGHTLY COLOCALIZES WITH UHRF1 AT CHROMOCENTERS IN 
HETEROCHROMATIN REPLICATION AND FORMATION 
Previous studies have found that MBD4 and UHRF1 respectively localize to heterochromatic sites in 
mouse cells [Dunican et al., 2013; Gelato et al., 2014; Hendrich and Bird, 1998; Karagianni et al., 
2008; Nady et al., 2011; Papait et al., 2007; Ruzov et al., 2009], suggesting they may be involved in 
heterochromatin regulation and maintenance. To determine if MBD4 occupies the same cellular space 
with UHRF1 at heterochromatin, and if their association affects particular cellular phenotypes such as 
chromatin organization, we performed co-transfection followed by immunofluorescence (IF) 
microscopy to determine their potential co-localization and subcellular distribution (Figure 3). We 
used mouse CMT93 cells, a colon cancer cell line that has prominent heterochromatin sites as 
evidenced by DAPI staining, to test our hypothesis that MBD4 and UHRF1 might associate with each 
other at heterochromatin sites.  
 
Ectopic GFP epitope-tagged mouse MBD4 protein exhibited a strong signal that was coincident with 
DAPI bright spots in the nucleus (Figure 3A. left & white arrows in right magnification); this 
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resembles the endogenous mouse MBD4 distribution [Hendrich and Bird, 1998; Ruzov et al., 2009]. 
The DAPI bright spots correspond to methylated satellite DNA, a natural methylated ligand for MBD4 
[Ruzov et al., 2009]. Additional non-heterochromatic staining of ectopic MBD4 is also observed in 
CMT93 cells (Figure 3A. MBD4 light green staining). FLAG epitope-tagged human UHRF1 showed a 
condensed nuclear distribution that also co-localized with DAPI bright dots (Figure 3B. left & right 
magnification), resembling the location of endogenous UHRF1 protein [Dunican et al., 2013; Gelato et 
al., 2014]. In CMT93 cells, ectopic expression of either MBD4 or UHRF1 induced minor 
heterochromatin clustering (Figure 3A & B, white arrows); a cellular phenomenon previously reported 
for overexpression of UHRF1 or MeCP2 [Brero et al., 2005; Papait et al., 2008; Papait et al., 2007]. 
UHRF1 has been demonstrated to regulate cell proliferation [Jenkins et al., 2005], and is expressed at 
high levels in proliferating cells [Papait et al., 2007]. Consistently and intriguingly, co-overexpression 
of UHRF1 and MBD4 resulted in marked large-scale reorganization events occurring at 
heterochromatic sites (Figure 3C. upper & lower magnification), manifested by either bridging (Figure 
3C. left), fragmentation (Figure 3C. middle), or major clustering (Figure 3C, right); possibly implying 
heterochromatin reformation (Figure 3C, left) or perhaps replication (Figure 3C, middle) occurs at 
their co-localization sites. The cells with such cellular phenotypes are concomitant with a marked 
increase in cell size (Figure 3 C vs. A & B). In all cases, ectopic MBD4 tightly co-localized with 
UHRF1 at chromocenters in CMT93 cells (Figure 3C i, ii, iii MBD4 vs. UHRF1 and Merge & 
Supplementary Figure 1B). Specifically, MBD4 and UHRF1 tightly occupied the same cellular space 
which may perturb chromocenter dynamics during heterochromatin replication and formation (Figure 
3C. lanes of MBD4, UHRF1 & Merge in i, ii & iii, black circle or square). Decondensin 
heterochromatin or remodeling at chromocenters was manifested by less intense DAPI bright spots, 
but did not lead to changes in the tight co-localization of MBD4 and UHRF1 (Figure 3C middle, DAPI 
lane & ii vs. i, iii, DAPI lane, white square or circle).. Interestingly, we observed some moderate co-
localization of MBD4 and UHRF1 that may be indicative of dividing cell nuclei (Figure 3Ciii. white 
arrows); forming ring-like clusters that are adjacent to their strong staining at chromocenters (Figure 
3Ciii. black arrows). This may represent an intermediate transition, in which MBD4 and UHRF1 are 
involved in large-scale reorganization of heterochromatin (Figure 3C iii. black arrows in DAPI lane).  
 
MBD4 DIRECTLY RECRUITS USP7 TO CHROMOCENTERS 
Consistent with our finding that MBD4 directly interacts with USP7, we also identified USP7 as an 
interactor in a Y2H assay using mouse Mbd4 protein as bait (Figure 4A), supporting the possibility 
that the interaction between MBD4 and USP7 is direct. The cDNA fragment of USP7 was aligned to 
USP7 coding sequence, and it overlaps with C-terminal TRAF-like domain of USP7 (Figure 4A 
vertical gray shadow), suggesting that this may be one route through which MBD4 directly interacts 
with USP7 at the vicinity of the TRAF-like binding domain of USP7.  
 
Despite different cellular system and conditions used, previous studies have reported a diffused 
distribution of USP7 within cell nuclei as well as some cytoplasmic staining [Holowaty et al., 2003; 
van der Horst et al., 2006]. We determined the subcellular localization of ectopic expression of 
MCherry epitope-tagged USP7 in the CMT93 cell model, and out data is consistent with the previously 
reported nuclear distribution of USP7 as diffused (Figure 4B. left). More specifically, we characterized 
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that the prominent DAPI bright spots were largely excluded from the nuclear distribution of USP7 
(Figure 4B. left & right magnification, white arrows), implying USP7 may require additional 
heterochromatin-associating interaction partner(s) to be recruited to the chromocenters where UHRF1 
is tightly bound. Indeed, a number of studies have shown that USP7 can be recruited and relocated to 
particular nuclear loci via physical interactions with its protein partners, to effectively participate in 
cellular processes such as DNA damage and repair, apoptosis, and innate immunity response [Daubeuf 
et al., 2009; Everett et al., 1997; Zaman et al., 2013]. Moreover, MBD4 has been reported to possess a 
recruitment function by which it leads to the re-distribution of diffused MLH1 to accumulate at DAPI 
bright spots that are associated with heterochromatic chromatin in MEF cells [Ruzov et al., 2009], and 
we have observed the same phenomenon in the CMT93 cell model (Supplementary Figure 1A). This 
suggested to us that MBD4 might possess the ability to participate in the UHRF1/Dnmt1/USP7 
trimeric complex by facilitating the recruitment of USP7 to the chromocenters. To address this 
question, we studied the subcellular localization of USP7 in the presence of ectopic MBD4 (Figure 
4C). GFP epitope-tagged MBD4 was detected exclusively at chromocenters (Figure 4C. green 
staining), to which UHRF1 was shown in Figure 3 to be tightly bound. Strikingly, chromocenter-
binding MBD4 was able to recruit USP7 to chromocenters in all co-transfected CMT93 cells tested 
(Figure 4C. MBD4, USP7 and Merge, white arrows & Supplementary Figure 1C). In agreement with 
the above observations of co-localization of MBD4 and UHRF1 in Figure 3, the MBD4-induced USP7 
relocation and their co-localization at chromocenters also leads to a degree of heterochromatin 
reorganization that was not evident in the single transfections (Figure 4C upper, left & right vs. middle 
DAPI lane & disappearing heterochromatin spots indicated by black arrows in 4C. ii & iii). We 
observed heterochromatin clustering and diminution (Figure 4C. i DAPI lane, white arrows), 
chromocenter linkage and fragmentation (Figure 4C. ii DAPI lane, white arrows), and marked 
heterochromatin remodeling at chromocenters (Figure 4C. iii DAPI lane, white arrows). Collectively, 
our data show that MBD4 directly interacts with and recruits USP7 to chromocenters during 
interphase, where MBD4 and UHRF1 can also be tightly co-localized and this is concomitant with 
large-scale reorganization of heterochromatin. 
 
DISCUSSION 
During cell proliferation, UHRF1 may act as a recruitment platform to facilitate faithful inheritance of 
DNA methylation patterns [Bostick et al., 2007; Sharif et al., 2007]. Mounting evidence indicates that 
USP7 can regulate the protein stability of UHRF1 as well as Dnmt1 through its deubiquitylase activity 
[Ma et al., 2012; Sharif et al., 2007]. In this report, we have shown that MBD4 can directly interact 
with and recruit USP7 to the UHRF1 platform at heterochromatin-associated chromocenters. 
Importantly, regulation of the interaction between UHRF1 and deubiquitylase USP7 has been shown to 
be cell cycle dependent [Ma et al., 2012]; UHRF1 is expressed and protected by USP7 from auto-
ubiquitinylation during G1 and S phases of the cell cycle, and M phase-specific phosphorylation of 
UHRF1 expels USP7 from UHRF1 platform [Ma et al., 2012], leading to proteasomal degradation of 
UHRF1 and perhaps Dnmt1 as well [Felle et al., 2011; Ma et al., 2012]. MBD4 may have a role in this 
process via its interaction with all three components.  
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Recent evidence indicates that the MBD4 protein is essential for cell survival following oxidative 
stress [Laget et al., 2014]. MBD4 and DNMT1 can be recruited at sites of oxidation-induced DNA 
damage, where they may participate in DNA repair or cell death pathways [Laget et al., 2014; Ruzov 
et al., 2009]. Although cell models and physiological conditions are different, our MBD4 interaction 
data suggest that UHRF1 and USP7 might also participate in these pathways. Our current study 
provides a foundation for future functional studies of these new MBD4 interactions and roles in related 
pathways of cell proliferation, stress response or DNA methylation machinery. 
 
The intervening region within MBD4 was previously viewed as a functional desert [Meng et al., 2011], 
our characterization strongly suggests that this region may possess a significant potential for novel 
protein interactions, which may augment MBD4’s well-characterized methyl-CpG binding and 
glycosylase repair functions [Meng et al., 2011; Millar, 2002; Screaton et al., 2003]. Motif and primary 
sequences of the intervening region are poorly conserved between lower and higher vertebrates, 
suggesting additional protein structure and/or motifs acquired in the latter may attract new functional 
interactions. This might link to recurrent frameshift mutations in MBD4 found in a number of human 
cancers exhibiting MMR deficiency resulting in human MBD4 protein truncation at amino acid 313, 
which would presumably deconstruct the interaction function of intervening region in addition to loss 
of the glycosylase domain of MBD4. 
 
Recent studies have documented the overexpression of MBD4 partner proteins, UHRF1 and USP7, in 
a variety of human cancers, which often correlate with a poor outcome [Mudbhary et al., 2014; Unoki 
et al., 2010; Unoki et al., 2009]. In addition, MBD4 activation has been shown to be a consequence of 
RON overexpression that results in reprogrammed DNA methylation at specific target genes, which is 
associated with metastasis and poor patient outcomes [Cunha et al., 2014]. Future studies will be 
required to address if the MBD4 protein interaction with UHRF1, USP7 and the previously identified 
partner DNMT1 have novel functions with respect to targeting specific methylation patterns at defined 
loci as well as in maintaining genome-wide methylation patterns at chromocenters. This interaction 
may also impact on nuclear organization, chromatin remodeling, and histone modifications in relevant 
cancers [Cunha et al., 2014; Jones, 2012].  
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Figure Legends 
Figure 1. MBD4 complexes with UHRF1 and USP7. (A) UHRF1 and USP7 are identified as new 
interaction partners of MBD4. MBD4 was immunoprecipitated from nuclear extracts with MNase 
treatment and subjected to SDS–PAGE and Coomassie blue staining. Protein bands of UHRF1 and 
USP7 specific for the FLAG-MBD4-IP were identified by MS analysis (ctrl: Empty vector). 
Precipitated MBD4 and the molecular weight marker (M) are indicated. (B) Immunoprecipitation of 
ectopic proteins with FLAG epitope-tagged (MNase treated nuclear extract) or GFP epitope-tagged (no 
MNase treated nuclear extract) with anti-FLAG or anti-GFP antibodies. Co-precipitated proteins were 
detected by Western Blot analysis. 3% of the input (Lane 1) and the antibody coupled IP (Lane 2) were 
loaded. The migration of the molecular weight is indicated on the left. 
Figure 2. MBD4 interacts with UHRF1 via its intervening region. (A) Schematic representation of the 
domains of MBD4 (MBD4 domains are to scale) and the representative scheme of generating the four 
MBD4 mutant proteins. A black arrow indicates the natural occurring MBD4 protein truncation site 
313 in human MMR-deficiency carcinomas. (B) The schematic representation of the fusion proteins of 
MBD4 mutants, and comaissie staining of the purified MBD4 proteins fused with trigger factor and 
ubiquitin. Respective total lysates of transformed E.coli cells of MBD4 mutants 1-4 and their protein 
elutions are shown as indicated. The dye marker lanes are indicated on the left of lysate lanes with 
their molecular weight. The empty vector control (labeled as 0. TFUB control) containing TFUB only 
was from pre-purified storage, and loaded on the left. The three elutions of individual MBD4 mutants 
were pooled together and 500μg of each MBD4 protein mutant was measured for the subsequent 
reciprocal co-immunoprecipitation (co-IP) assays. (C) Flow chart of the reciprocal co-IP procedure. (D 
& E) Co-IP assay to determine the interaction of recombinant MBD4 mutants with Mlh1 (D. control) 
and UHRF1 (E). Co-precipitated proteins were detected via western blot. Input (3% of 500μg GFP-
Mlh1 (D. 6HIS IP) or FLAG-UHRF1 (E. 6HIS IP), and 3% of 500μg MBD4 protein mutants in D and 
E) and the antibody coupled IP are indicated with antibodies used for immunodetection. The migration 
of the molecular weight is indicated on the left of each blot. The regions labelled by a square on the 
schematic representation of MBD4 are identified the interacting domains responsible for the 
associations with Mlh1 (D. control) and UHRF1 (E). 
Figure 3. MBD4 tightly co-localizes UHRF1 at chromocenters. Asynchronously growing mouse 
CMT93 cells were grown on coverslips and transfected by GFP-MBD4 (A), FLAG-UHRF1 (B), or co-
transfected by GFP-MBD4 and FLAG-UHRF1 (C). The cells were fixed 48 hours later and analyzed 
directly by immunofluorescence (IF) (A), or immunostained with anti-FLAG rabbit primary and goat 
anti-rabbit IgG-Alexafluor Red conjugate secondary antibodies and analyzed (B & C). Nuclear 
counterstaining was visualized with DAPI. Scale bars, 10μm. (A) Distribution of GFP-MBD4 in 
CMT93 cells. (B) Distribution of FLAG-UHRF1 in CMT93 cells. (C) GFP-MBD4 and FLAG-UHRF1 
exclusively colocalized with each other at chromocenters in CMT93 cells. In the immunostaining 
images in (C. i & ii), the cells exhibit an increase in cell size and marked large-scale reorganization of 
heterochromatin, which may be indicative of heterochromatin reformation and replication in interphase. 
In (C. iii), the cells appear to be undergoing orderly division into two daughter cells. The insets on the 
right (A & B) or below (C. i, ii, iii) correspond to magnifications of the areas indicated by the two 
parallel white line. Scale bars, 10μm. 
Figure 4. MBD4 directly interacts with and recruits USP7 to chromocenters. (A) The representative 
scheme for alignment and mapping of a USP7 cDNA fragment that iinteracts with MBD4 in a Y2H 
screen (i) USP7 coding sequence (ii) corresponding peptide sequence (iii), schematic representation of 
domains of USP7. Protein domains are identified by searching Blast integrated SMART domain 
database (USP7 domains are to scale). The vertical gray shadow indicates the domain region of USP7 
overlapping with interacting cDNA fragment. (B & C) Asynchronously growing mouse CMT93 cells 
were grown on coverslips and transfected by MCherry-USP7 (B), or co-transfected by GFP-MBD4 
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and MCherry-USP7 (C). The cells were fixed 48 hours later and analyzed directly by IF. Nuclear 
counterstaining was visualized with DAPI. (B) Distribution of MCherry-USP7 in CMT93 cells. (C) 
GFP-MBD4 recruits MCherry-USP7 exclusively to chromocenters in all the CMT93 cells co-
transfected. In all the immunostaining images in C, the cells exhibit marked heterochromatin 
remodeling. The insets on the right (B) or below (C. i, ii, iii) correspond to magnifications of the areas 
indicated by the two parallel white line. White arrows indicate triple co-localization of MBD4, USP7 
and DAPI bright spots, while black arrows indicate colocalization of MBD4 and USP7 with 
diminishing or disappearing DAPI bright spots. Scale bars, 10μm. 
Supplementary Figure 1. Co-localization of MBD4 with Mlh1, UHRF1, and recruitment of USP7 at 
heterochromatic foci. (A) MBD4 recruits Mlh1 to bright DAPI spots that are tightly associated with 
heterochromatic condensed chromatins. Mouse CMT93 cells were grown asynchronously, then 
transfected, stained and analyzed as in (Figure 3 & 4). (i) Diffused nucleus distribution pattern of 
MLH1 in which heavily stained DAPI spots were excluded from the MLH1 distribution. (ii) Co-
transfection of FLAG-MBD4 and GFP-Mlh1 resulted in the recruitment of GFP-MLH1 to DAPI bright 
spots. (B) MBD4 tightly colocalizes UHRF1 at chromocenters in all the cells co-transfected. 
Additional examples are represented to supplement Figure 3. (C) MBD4 recruits USP7 to 
chromocenters in all the cells co-transfected. More cells are represented to supplement Figure 4. Scale 
bars, 10μm. 
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